Shivalik Rasayan Ltd (SHIVALIK) — shareholding pattern, promoter holding, financials and share price
About Shivalik Rasayan Ltd (SHIVALIK)
Shivalik Rasayan Ltd operates in the Pesticides & Agrochemicals industry, within the Chemicals sector. It trades on the NSE as SHIVALIK and on the BSE under scrip code 539148. Its ISIN is INE788J01021.
Incorporated in 1979, Shivalik Rasayan Ltd is a manufacturer of Agrochemicals & Active Pharma Ingredients [1]
Shivalik Rasayan Limited is primarily engaged in manufacturing organophosphate insecticides, including Dimethoate Technical and Malathion Technical.
In 2016, Shivalik Rasayan acquired a significant share in Medicamen Biotech Limited, gaining full management control in the process.
Listed peers in Pesticides & Agrochemicals: Best Agrolife Ltd, KN Agri Resources Ltd, Indogulf Cropsciences Ltd, Mahamaya Lifesciences Ltd, Sikko Industries Ltd, Shreeoswal Seeds & Chemicals Ltd.
Valuation & Returns
10 Jul 2026At ₹221.95 a share on 10 Jul 2026, Shivalik Rasayan Ltd (SHIVALIK) was valued at a price-to-earnings ratio of 19.46x against an industry P/E of 22.12x and a price-to-book of 0.58x on a book value of ₹380.38 per share. Solomo computes return on equity of 2.03% and return on capital employed of 4.36% from filed results. Earnings ratios use consolidated results for the twelve months Jun 2025 to Mar 2026.
- P/E
- 19.46x
- Industry P/E
- 22.12x
- P/B
- 0.58x
- EPS (TTM)
- ₹11.4
- Book value / share
- ₹380.38
- ROE
- 2.03%
- ROCE
- 4.36%
- ROA
- 2.19%
- Debt / equity
- 0.19x
- Dividend yield
- 0.23%
- EBITDA margin
- 13.54%
- 52-week range
- ₹206 – ₹652.75
Ratios are computed from filed results and the last recorded price. Not investment advice.
Financial Performance
Mar 2026In the year ended Mar 2026, Shivalik Rasayan Ltd (SHIVALIK) reported revenue of ₹368 crore, net profit of ₹18 crore and earnings per share of ₹7.71. That compares with revenue of ₹312 crore and net profit of ₹20 crore in Mar 2025. Figures are consolidated, as filed with the exchanges.
In the quarter ended Mar 2026, revenue was ₹102.82 crore and net profit ₹7.18 crore (consolidated).
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue (₹ cr) | 215 | 234 | 273 | 312 | 368 |
| Net profit (₹ cr) | 34 | 30 | 18 | 20 | 18 |
| EPS (₹) | 17.68 | 14.32 | 8.17 | 10.6 | 7.71 |
| Measure | 10Y | 5Y | 3Y | 1Y |
|---|---|---|---|---|
| Sales growth | 13.45% | 19.68% | 14.54% | 14.21% |
| Profit growth | 20.09% | 9.64% | -10.52% | 12.63% |
| Stock price CAGR | 19% | -25% | -34% | -63% |
Ownership Summary
Jun 2026As of Jun 2026, promoters hold 47.37% of Shivalik Rasayan Ltd (SHIVALIK) (unchanged from the previous quarter), foreign institutional investors (FII) hold 1.19% and domestic institutional investors (DII) hold 0.02%. Market capitalisation was ₹350 crore on 10 Jul 2026. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Mar 2015.
Largest disclosed public shareholders in Jun 2026: Ginnerup Capital ApS 3.22%, HUF 2.57%, ERIC AARESTRUP SORENSEN 2.13%, Ritesh Kantilal Oswal 1.02%, Sanjay Bansal 1.02%. Only stakes above the 1% disclosure threshold are named in filings.
| Quarter | Promoter | Pledged | FII | DII | Public |
|---|---|---|---|---|---|
| Jun 2026 | 47.37% | - | 1.19% | 0.02% | 52.63% |
| Mar 2026 | 47.37% | - | 4.2% | - | 52.63% |
| Dec 2025 | 47.37% | - | 3.89% | 0.12% | 52.63% |
| Sep 2025 | 47.37% | - | 4.38% | 0.48% | 52.63% |
| Jun 2025 | 47.37% | - | 4.36% | 0.56% | 52.63% |
| Mar 2025 | 47.37% | - | 4.27% | 0.64% | 52.63% |
| Dec 2024 | 47.95% | - | 4.34% | 0.88% | 52.05% |
| Sep 2024 | 47.95% | - | 3.29% | 0.88% | 52.05% |